Not applicableStudy completedNCT03541629What this trial is testingAudit of the Spanish EURECCA Esophagogastric Cancer RegistryWho this might be right forCancer of StomachCancer of Esophagus Parc de Salut Mar 1,839
Not applicableUnknownNCT04484311What this trial is testingNon-curative ESDs: Assessing the Rates and Risk Factors for Residual NeoplasiaWho this might be right forGastric NeoplasmEsophageal NeoplasmsColorectal Neoplasms Universidade do Porto 300
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Not applicableLooking for participantsNCT05642819What this trial is testingREVOLUTION Surgery (REVOLUTION Surgery)Who this might be right forCachexiaOesophageal CancerGastric Cancer+2 more University of Edinburgh 200
Very early researchLooking for participantsNCT06645808What this trial is testingPET-imaging of Two Vartumabs in Patients With Solid TumorsWho this might be right forSolid TumorColon CarcinomaRectal Carcinoma+11 more Var2 Pharmaceuticals 32
Testing effectiveness (Phase 2)Ended earlyNCT01579578What this trial is testingAssess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerWho this might be right forMetastatic, Gastric or Gastro-oesophageal Junction, Cancer AstraZeneca 39
Early research (Phase 1)Active Not RecruitingNCT05539430What this trial is testingClaudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaWho this might be right forGastric CancerGastroesophageal-junction CancerEsophageal Cancer+1 more Legend Biotech USA Inc 56
Testing effectiveness (Phase 2)Study completedNCT00374985What this trial is testingSafety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal JunctionWho this might be right forEsophageal NeoplasmsStomach Neoplasms Johannes Gutenberg University Mainz 25
Testing effectiveness (Phase 2)UnknownNCT03995017What this trial is testingRucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal AdenocarcinomaWho this might be right forEsophagus Cancer, AdenocarcinomaStomach Cancer, Adenocarcinoma University of Kansas Medical Center 34
Not applicableUnknownNCT06046846What this trial is testingPrehabilitation Via a Mobile Application in Oesophago-gastric CancerWho this might be right forOesophageal CancerGastric CancerPrehabilitation+1 more Queen Margaret University 20
Testing effectiveness (Phase 2)Study completedNCT00525785What this trial is testingPreoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)Who this might be right forStomach CancerGastric Cancer M.D. Anderson Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00017043What this trial is testingBMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyWho this might be right forEsophageal CancerGastric Cancer Bristol-Myers Squibb
Testing effectiveness (Phase 2)Ended earlyNCT01457846What this trial is testingEfficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal CancerWho this might be right forGastro-oesophageal Junction CancerGastric Cancer AstraZeneca 960
Testing effectiveness (Phase 2)Study completedNCT01913639What this trial is testingFOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Very early researchUnknownNCT04400136What this trial is testingPPI Therapy Impact on GERD After Sleeve GastrectomyWho this might be right forGastro Esophageal RefluxBarrett EsophagusBariatric Surgery Candidate University of Roma La Sapienza 45
Testing effectiveness (Phase 2)Study completedNCT01585987What this trial is testingAn Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line ChemotherapyWho this might be right forLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction Bristol-Myers Squibb 143
Early research (Phase 1)Not Yet RecruitingNCT07738939What this trial is testingIKS04 Regimen in Advanced Solid Tumors That Express CA242Who this might be right forColorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more Iksuda Therapeutics Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT01178944What this trial is testingPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more Roswell Park Cancer Institute 35
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112